Astrazeneca PLC DRC (AZNN)

Featured here, the Balance Sheet for Astrazeneca PLC DRC, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).

1,284.94 +0.00 (+0.00%)

01/06 Close MXN Disclaimer

AZNN Balance Sheet

Total Current Assets

Name	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
Total Current Assets	22,266	22,593	20,224	20,917	22,647
Cash and Short Term Investments	6,462	6,243	4,522	4,887	5,823
Cash	-	-	-	-	-
Cash & Equivalents	6,232	6,166	4,458	4,817	5,762
Short Term Investments	230	64	64	70	61
Total Receivables, Net	10,797	11,252	10,061	9,612	9,050
Accounts Receivables - Trade, Net	10,289	10,521	9,336	8,908	8,683
Total Inventory	4,967	4,699	5,078	6,220	7,624
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	40	399	563	198	150
Total Assets	96,687	96,483	94,185	96,579	100,273
Property/Plant/Equipment, Total - Net	9,599	9,449	9,227	9,627	10,015
Property/Plant/Equipment, Total - Gross	-	-	-	-	-
Accumulated Depreciation, Total	-	-	-	-	-
Goodwill, Net	20,001	19,820	19,707	19,821	19,963
Intangibles, Net	39,291	39,307	39,585	39,900	41,265
Long Term Investments	1,234	1,142	1,102	1,180	1,237
Note Receivable - Long Term	508	731	725	704	367
Other Long Term Assets, Total	798	909	904	994	951
Other Assets, Total	-2,062	-1,485	-920	1,016	2,980
Total Current Liabilities	24,860	26,293	24,850	21,815	22,740
Accounts Payable	18,418	2,550	16,842	16,983	17,040
Payable/Accrued	-	-	-	-	-
Accrued Expenses	-	-	-	-	-
Notes Payable/Short Term Debt	667	350	743	747	805
Current Port. of LT Debt/Capital Leases	4,026	1,188	5,795	2,563	2,348
Other Current liabilities, Total	1,749	3,814	1,470	1,522	2,547
Total Liabilities	60,876	59,425	59,031	60,628	63,914
Total Long Term Debt	27,779	24,633	24,737	28,078	29,592
Long Term Debt	27,049	23,908	24,069	27,393	28,868
Capital Lease Obligations	730	725	668	685	724
Deferred Income Tax	2,795	2,944	3,479	5,275	5,626
Minority Interest	22	21	20	19	19
Other Liabilities, Total	4,753	-4,057	846	386	854
Total Equity	35,811	37,058	35,154	35,951	36,359
Redeemable Preferred Stock, Total	-	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-	-
Common Stock, Total	387	387	387	387	387
Additional Paid-In Capital	35,159	35,155	35,137	35,134	35,131
Retained Earnings (Accumulated Deficit)	-1,825	-574	-2,471	-1,657	-1,228
Treasury Stock - Common	-	-	-	-	-
ESOP Debt Guarantee	-	-	-	-	-
Unrealized Gain (Loss)	-	-	-	-	-
Other Equity, Total	2,090	-1,604	2,101	2,087	2,069
Total Liabilities & Shareholders' Equity	96,687	96,483	94,185	96,579	100,273
Total Common Shares Outstanding	1,549	1,549.80	1,548	1,549	1,548
Total Preferred Shares Outstanding	-	-	-	-	-

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.